source Post navigation Orlando Health doctor raises awareness about diabetes prevention – WKMG News 6 & ClickOrlando Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% – Investors | Eli Lilly and Company